期刊文献+

高嗜酸粒细胞综合征心血管损害的临床分析 被引量:7

Cardiovascular manifestations in Chinese patients with hypereosinophilic syndrome
原文传递
导出
摘要 目的 分析高嗜酸粒细胞综合征(HFS)心血管损害的临床特点.方法 收集北京协和医院149例HES患者的临床资料,分析心血管损害的发生率及类型.结果 149例HES患者中,心血管受累患者共49例(32.9%),其中女性15例,男性34例,年龄1.5~78.0(41.3±16.9)岁,病程14 d~164个月(26.4±72.3)个月.其心血管受累分别表现为心电图ST-T异常或心律失常、心肌或心内膜损害、心内血栓形成、心包积液、肺动脉高压、瓣膜病变、动脉或静脉血栓形成和其他心血管损害.49例患者中11例(22.4%)经对症治疗后症状有改善但仍反复发作,3例(6.1%)患者治疗无效死亡.与单纯非特异性心电图异常患者(21例)相比,存在超声心动图异常的HES者(28例)中有更多患者需要接受激素和免疫抑制剂的联合治疗(前者使用单一激素与联合治疗分别为15例、6例,后者分别为16例、12例,P=0.044)且预后更差(两组死亡例数分别为0例与3例,P=0.029).结论 心血管损害是HES的常见并发症,表现复杂多样,超声心动图评估心血管受累简单有效,心血管受累是提示预后的危险因素. Objective To evaluate the cardiovascular involvements in Chinese patients with hypereosinophilic syndrome. Method We respectively reviewed 149 inpatients with hypereosinophilic syndrome admitted to Peking Union Medical College Hospital and analyzed the cardiovascular involvements in these patients. Results Cardiac abnormalities was evidenced in 32.9% patients (49/149) . The ratio of was ( 26.4 ± 72.3 ) months. Cardiovascular involvements included ST segment and/ or T wave (ST-T)ischemic changes, arrhythmia, myocardial injury, cardiac thrombosis, pericardial effusion, pulmonary hypertension, valve disorder, vein or artery thrombosis. After glucocorticoid and/or chemotherapeutic agents and treatment for symptoms, 11 ( 22.4% ) patients achieved remission but have recurrent attacks and 3 (6.1%) patients died from failure in treatment. The prognosis in patients with echocardiogram abnormalities were poorer than those only with electrocardiogram abnormalities ( P 〈 0.05 ) . Conclusions Cardiovascular involvements are common in patients with hypereosinophilic syndrome and the manifestation of these involvement is various. Cardiovascular complications of HES are a major source of morbidity and mortality in these disorders.
出处 《中华心血管病杂志》 CAS CSCD 北大核心 2010年第10期905-908,共4页 Chinese Journal of Cardiology
关键词 心血管疾病 心电描记术 超声心动描记术 高嗜酸粒细胞综合征 Cardiovascular diseases Electrocardiography Echocardiography Hypereosinophilic syndromes
  • 相关文献

参考文献10

  • 1Brito-Babapulle F.The eosinophilias,including the idiopathic hypereosinophilic syndrome.Br J Haematol,2003,121:203-223.
  • 2Ogbogu PU,Rosing DR,Home MK 3rd.Cardiovascular manifestations of hypereosinophilic syndromes.Immunol Allergy Clin North Am,2007,27:457-475.
  • 3Klion AD,Bochner BS,Gleich GJ,et al.Approaches to the treatment of hypereosinophilic syndromes:a workshop summary report.J Allergy Clin Immunol,2006,117:1292-1302.
  • 4Weller PF,Bubley GJ.The idiopathic hypereosinophilic syndrome.Blood,1994,83:2759-2779.
  • 5Cools J,DeAngelo DJ,Gotlib J,et al.A tyrosine kinase created by fusion of the PDGFRA and FIPI L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome.N Engl J Med,2003,348:1201-1214.
  • 6Shah R,Ananthasubramaniam K.Evaluation of cardiac involvement in hypereosinophilic syndrome:complementary roles of transthoracic,transesophageal,and contrast echocardiography.Echocardiography,2006,23:689-691.
  • 7Ommen SR,Seward JB,Tajik AJ.Clinical and echocardiographic features of hypereosinophilic syndromes.Am J Cardiol,2000,86:110-113.
  • 8Gudmundsson GS,Ohr J,Leya F,et al.An unusual case of recurrent Loffler endomyocarditis of the aortic valve.Arch Pathol Lab Med,2003,127:606-609.
  • 9Kanno H,Ouchi N,Sato M,et al.Hypereosinophilia with systemic thrombophlebitis.Hum Patho1,2005,36:585-589.
  • 10Funahashi S,Masaki I,Furuyama T.Hypereosinophilic syndrome accompanying gangrene of the toes with peripheral arterial occlusion--a case report.Angiology,2006,57:231-234.

同被引文献29

  • 1王琳娜,陈赛娟.原发性嗜酸粒细胞增多症分类诊断、发病机制和治疗研究进展[J].国际输血及血液学杂志,2006,29(5):419-422. 被引量:7
  • 2周文艳,鲁珊,常艳美,童笑梅.儿童特发性嗜酸性粒细胞增多综合征1例报告[J].北京医学,2007,29(5):318-318. 被引量:2
  • 3Hosoki K, Naqao M , Iquchi K, et al. An 8-year-old boy with hypereosinophilie syndrome [J]. Int Arch Allergy Immunol, 2011, 155 (S1):117-122.
  • 4Noureen N, Rana MT. Hypereosinophilic syndrome causing acute hemiplegia in childhood [J]. J Coil Physicians Surq Pak, 2008,18(6) :384-385.
  • 5Oqboqu PU, Bochner BC, Butterfleld JH, et al. Hypereosino- philic syndrome: multicenter, retrospective analysis of clinical characteristics and response to therapy [J]. J Allergy Clin Im- munol, 2009, 124(6) : 1319-1325.
  • 6Butterfield JH. Treatment of hypereosinophilic syndromes with prednisone, hydroxyurea, and interferon [J]. Immunol Allergy Clin North Am, 2007, 27(3) :493-518.
  • 7Klion AD, Law MA, Noel P, et al. Safety and efficacy of the mono-clonal anti-interleukinn-5 antibody SCH55700 in the treatment of patients with hypereosinophilic syndrome [J]. Blood, 2004,103(8) :2939-2941.
  • 8Roufosse FE, Goldman M, Cogan E. Hypereosinophilic syndromes[J]. Orphanet J Rare Dis, 2007, 2 : 37.
  • 9Chusid M J, Dale DC, West BC, et al. The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine,1975,54( 1 ) : 1-27.
  • 10Pardanani A, Brockman SR, Paternoster SF, et al. FIP1LI-PDGFRA fusion : prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia. Blood, 2004,104(10) :3038-3045.

引证文献7

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部